Zipalertinib is an investigational, oral, EGFR tyrosine kinase inhibitor designed to selectively inhibit EGFR variants with ex20ins mutations.

A qualitative study evaluated the information-seeking behaviors of patients undergoing genetic testing for hereditary breast cancer.

In this study, researchers surveyed nurses at the Turkish Palestinian Friendship Hospital in Gaza about safe ...

Researchers evaluated a low-dose chemotherapy induction regimen compared with standard-dose therapy in pediatric patients with AML.

Angelica” is the name assigned to an AI program deployed last year by Kern Family Health Care, the largest provider of ...

A contemporary systematic review and meta-analysis of 103 mostly retrospective studies characterized the efficacy and safety of renal tumor biopsy.

In this analysis, researchers analyzed patient-level estimates of cancer-attributable costs based on clinical and ...

Investigators assessed whether acalabrutinib could overcome age-related toxicity limitations that prevented successful combination of ibrutinib with R-CHOP in previously untreated patients with DLBCL.

In this study, researchers evaluated the germline variants of patients receiving CAR T-cell therapy to screen for the effects of mutations on CAR T-cell behavior in humans.

Accelerated approval is based on objective response rate and duration of response from the phase 2 IGNYTE trial in anti-PD-1-pretreated advanced melanoma.

Taylor Fresh Foods of Salinas, California, announced the voluntary recall Sunday after learning that its pepper supplier was recalling fresh jalapeños tied to a multistate outbreak, according to a ...

The latest systematic review on kidney tumor enucleation vs partial nephrectomy includes contemporary robot-assisted series and randomized studies.